Prevention Clinical Trials for Non-Small Cell Lung Cancer

Clinical trials are research studies that involve people. The clinical trials on this list are for non-small cell lung cancer prevention. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-2 of 2
  • Isoquercetin in Preventing Venous Thromboembolic Events in Patients with Metastatic or Unresectable Pancreatic Cancer, Stage III-IV Non-small Cell Lung Cancer, or Stage IV Colorectal Cancer

    This partially randomized phase II / III trial studies how well isoquercetin works in preventing blood clots (venous thromboembolic events) in patients with pancreatic cancer that has spread to other places in the body or that cannot be removed by surgery, stage III-IV non-small cell lung cancer, or stage IV colorectal cancer. Isoquercetin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
    Location: 10 locations

  • BIO 300 Non-Small Cell Lung Cancer Study

    The purpose of this study is to determine the safety and effectiveness of BIO 300 Oral Suspension when used in combination with standard dose radiation therapy and chemotherapy in patients with non-small cell lung cancer. Based on preclinical data the investigators hypothesize that BIO 300 Oral Suspension will reduce the incidence of radiation-induced pneumonitis and pulmonary fibrosis.
    Location: University of Maryland / Greenebaum Cancer Center, Baltimore, Maryland